Barrett's esophagus is an acquired condition in which normal squamous epithelium of the distal esophagus is replaced by intestinal-type metaplastic columnar epithelium with goblet cells. 1 It is considered to be induced by chronic gastroesophageal reflux disease (GERD), and B10% of patients with GERD are found to have Barrett's esophagus in an esophagogastroduodenoscopy examination. 2 Barrett's esophagus is considered, at least in part, to arise from gastric-type metaplastic epithelium in the esophagus that developed by chronic gastroesophageal reflux. The presence of Barrett's esophagus is one of the predominant risk factors for development of esophageal adenocarcinoma (EAC), and the incidence of EAC derived from Barrett's esophagus has steadily increased during the previous 2 decades in most countries. 3, 4 Barrett's esophagus affects B2% of the Western population and progresses to EAC in 0.5% of these patients each year. 5, 6 Several clinical studies have suggested that reflux of duodenal contents with bile acids contributes to the development of Barrett's esophagus. [7] [8] [9] [10] Although there is great interest in the pathogenesis of the condition, little is known regarding the mechanism of cellular metaplasia of Barrett's epithelium.
A number of studies have shown that Cdx2 is one of the most important mediators in the development of Barrett's esophagus. 11, 12 We previously reported a two-step mechanism involved in the development of Barrett's epithelium, in which bile acids activate the Cdx2 promoter via nuclear factor-kB (NF-kB) and stimulate the production of Cdx2 protein in esophageal immature keratinocytes, with resulting production of intestinal-type mucin. 13 In addition to Cdx2, ATOH1 (a factor associated with Notch signaling) is known to be an important transcriptional activator of the intestinal-specific gene MUC2. 14, 15 The Notch signaling pathway is a fundamental molecular signaling system that governs cell-fate decisions such as differentiation, proliferation, and apoptosis in numerous tissue types. 16 The function of Notch signaling has been studied in the intestinal epithelium of mice deficient in Hes1, which leads to loss of Notch signaling and an increase in the number of goblet cells and endocrine cells, along with a decrease in absorptive epithelial cells. 17 Although analysis of the function of Notch signaling in preservation of esophageal squamous epithelium has not been reported, studies on the effects of Notch signaling in the development of Barrett's esophagus, possibly after loss of homeostasis, have been occasionally presented. 18, 19 Recent findings have shown a relationship between the Notch signaling pathway and Cdx2 expression. It was reported that induction of Cdx2 in intestinal epithelium leads to induction of ATOH1, which plays an important role in differentiation of stem cells into goblet cells. 20 Furthermore, an analysis of the genes expressed and induced by the Cdx2 gene revealed a significant reduction in the expression of the Hes1 gene following Cdx2 induction. 21 Thus, Notch signaling activation leads to Hes1 upregulation and ATOH1 downregulation, along with suppression of stem cell differentiation into goblet cells. 15 Therefore, it is plausible that enhanced expression of Cdx2 by chronic inflammatory stimulation (eg, GERD) leads to Hes1 downregulation and ATOH1 upregulation, which in turn enhances the differentiation of stem cells into goblet cells. However, the relationship between the Notch signaling pathway and Cdx2 expression in the development of Barrett's esophagus accompanied by goblet cells has not been reported.
In the present study, we investigated the interaction between the Notch signaling pathway and Cdx2 expression in the development of intestinal-type esophageal metaplasia with goblet cells from columnar metaplasia without goblet. Furthermore, we investigated the complicated mechanisms related to the Notch signaling pathway and Cdx2 expression in the development of esophageal intestinal metaplasia (IM): Barrett's esophagus.
MATERIALS AND METHODS Patients and Human Esophageal Tissue
A total of 71 patients (43 males, mean 67.7 years old) treated from August 2008 to July 2009 were enrolled in the study, including 44 with columnar-lined esophagus (CLE) and 27 with a normal esophagus. The esophagogastric junction was defined as the proximal margin of the gastric folds. Biopsy samples were precisely taken from CLE specimens, and then snap-frozen in liquid nitrogen. We divided 51 lesions from 44 patients with CLE into two groups based on histopathological findings: (1) lesions of columnar epithelium not accompanied by goblet cells (n ¼ 30) and (2) lesions of intestinal columnar epithelium accompanied by goblet cells (n ¼ 21). Human tissue specimens were obtained from patients who underwent an endoscopic examination at Shimane University Hospital with a GIF-H260, H260Z, or Q260J endoscope (Olympus Medical Systems, Tokyo, Japan). All endoscopic examinations were performed by well-trained expert endoscopists (TY, NI, SI, and YA), and endoscopic diagnosis was established by consensus of at least three of these four endoscopists. The study protocol was prepared according to the Declaration of Helsinki and approved by the ethics committee of Shimane University, Faculty of Medicine. Written informed consent was obtained from all patients.
Histopathology
Histopathological analysis was performed using tissues sectioned into 5-mm slices, and stained with hematoxylin and eosin (HE) for light microscopy examinations. Biopsy specimens were immediately placed in a 10% buffered formalin solution, routinely processed, and embedded in paraffin, with nine sequential sections obtained. Two sections were stained with HE and periodic acid-Schiff (PAS) Alcian blue staining, and a histological diagnosis of Barrett's esophagus was made when specialized columnar epithelium containing goblet cells with acid mucin was identified in the biopsy specimen by PAS Alcian blue staining. 22 The remaining seven sequential sections were used for immunohistochemical examinations, as described below. The mucin phenotype was determined following histological diagnosis of Barrett's epithelium with the biopsy specimens. Antibodies against human gastric mucin (HGM) (Novocastra, Newcastle, UK) and MUC2 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) were used for phenotyping of Barrett's esophagus, as previously described. 23 When Barrett's epithelial cells were more dominantly stained by the anti-MUC2 antibody, the case was diagnosed as Barrett's esophagus with intestinal predominant mucin phenotype.
Immunohistochemistry
Immunolabeling was performed using formalin-fixed, paraffin-embedded blocks (5 mm thick). Freshly cut sections were deparaffinized in xylane and rehydrated through sequential graded ethanol steps. The tissue sections were incubated with primary antibodies, followed by incubation with secondary biotinylated antibodies (DAKO, Carpinteria, CA, USA). Bound antibodies were detected using an avidinbiotin peroxidase method (ABC Elite Kit; Vector Laboratories, Burlingame, CA, USA). The sections were then counterstained with HE. The antibodies and dilutions used are summarized in Table 1 . Mounted slides were examined by light microscopy and immunoreactivity was assessed by four independent observers (YT, NI, GU, and YA) using a three-grade system, in which 0 denoted absence of staining; 1 denoted minimal and variable staining; and 2 denoted obvious, uniform, and intense staining. Only specimens with grade 2 immunoreactivity were considered positive.
Cell Culture and Treatments
Three cell lines, including OE33 (a human esophageal adenocarcinoma cell line; European Collection of Cell Cultures (ECACC), Salisbury, Wiltshire, UK), OE19 (a human cell line established from adenocarcinoma obtained from gastric cardia/esophageal gastric junction; ECACC), and Het-1A (a human esophageal squamous epithelial cell line immortalized by viral SV40 transfection; American Type Culture Collection (ATCC), Manassas, VA, USA) were used in this study. OE33 cells are poorly differentiated and OE19 cells are moderately differentiated EAC cells. 24 All cells were maintained in monolayer culture at 37 1C in a humidified incubator containing 5% carbon dioxide (CO 2 ). OE33 cells and OE19 cells were cultured in RPMI-1640 (Invitrogen, Carlsbad, CA, USA) medium supplemented with 2 mM glutamine, 10% fetal bovine serum (FBS), 100 U/ml penicillin G, and 100 mg/ml streptomycin (all from Invitrogen). Het-1A cells were cultured in BEBM (Lonza, Walkersville, MD, USA) medium supplemented with 100 U/ml penicillin G and 100 mg/ml streptomycin (all from Invitrogen). Subconfluent cells were split and subcultured on plastic dishes until 70% confluent, and then serum-starved 24 h before the experiments. All cell culture experiments were performed in triplicate to ensure reproducibility. After reaching B70% confluence, the cells were incubated with increasing concentrations of deoxycholic acid (DCA) or cholic acid (CA) (all from Sigma Chemical, St Louis, MO, USA; 50, 100, and 200 mM for each cell line) at neutral pH for up to 12 h, or with an increasing concentration of the g-secretase inhibitor N-(N-(3,5-difluorophenacetyl-Laranyl)-S-phenylglicine)-t-butyl ester (DAPT) (Calbiochem, Darmstadt, Germany; 5, 10, and 20 mM for each cell line) for up to 48 h. Inhibition of Notch signaling was achieved by addition of DAPT. For the experimental groups at neutral pH, the media were titrated to the corresponding pH before addition of the other components and pH was verified again thereafter. The cells were then incubated for the indicated time periods. RNAs or proteins were extracted as described below. Incubation time, DCA, CA, DAPT, and concentrations were chosen according to the criteria described elsewhere. 18, [25] [26] [27] RNA Extraction and Complementary DNA (cDNA) Syntheses Total RNA was extracted using a single-step guanidium thiocyanate-phenol-chloroform method (Isogen; Nippon Gene, Tokyo, Japan), according to the manufacturer's instructions. Total RNA concentrations were determined by spectrophotometric quantification at 260 nm using Nanodrop (type ND-1000; NanoDrop Technologies, Wilmington, DE, USA) and the integrity of the bands was verified visually by agarose gel electrophoresis. For real-time reversetranscription polymerase chain reaction (PCR) assays, cDNA was synthesized from 0.5 mg total RNA using an AffintyScriptt QPCR cDNA Synthesis Kit (Stratagene, La Jolla, CA, USA), according to the manufacturer's protocol, and the final reaction was diluted fivefold in RNase-free water.
Real-Time PCR For real-time PCR, 2 ml of cDNA and primers were mixed with POWER SYBR -Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA) in a final reaction volume of 20 ml, then assayed using a StepOnePlust Real Time PCR System (Applied Biosystems) as directed by the manufacturer. We used primer sequences for human glyceraldehyde-3-phosphate dehydrogenase (GAPDH), Notch1, Hes1, ATOH1, Cdx2, and MUC2. The GAPDH subunit was used as the normalization control. Notch1, Hes1, ATOH1, Cdx2, and MUC2 messenger RNAs (mRNAs) were quantitated using real-time PCR technology. The primer sequences used and amplicon size are summarized in Table 2 . Real-time PCR products were subjected to melting curve analysis. Agarose gel electrophoresis showed the expected band. Data are expressed as the ratio of product copies/ml to copies/ml of the housekeeping gene GAPDH from the same RNA (respective complementary DNA) sample and subjected to PCR. Results are expressed as the mean ± s.e.m. of data collected from three rounds of assays. Each assay was performed in triplicate experiments. Cell lysates were subjected to centrifugation at 14 000 g for 15 min at 4 1C. The supernatants were collected and protein concentrations determined using a bicinchoninic acid (BCA) protein assay reagent kit (Pierce Biotechnology) according to the manufacturer's instruction manual. Absorbance at 545 nm was measured using Nanodrop (NanoDrop Technologies). Bovine serum albumin (BSA) served as the standard. The lysates were diluted 1:1 in Electrophoresis Sample Buffer (glycerol, 2-mercaptoethanol, SDS, 1.0 M Tris-HCl (pH 6.7), and bromophenol blue; Santa Cruz Biotechnology) and incubated for 5 min at 95 1C.
Western Blot Analysis
Samples (20 mg/lane) were analyzed using 6 or 10% SDSpolyacrylamide gel electrophoresis (SDS-PAGE) according to the method of Laemmli. 28 Proteins were electro-transferred to polyvinylidene difluoride (PVDF) membranes (Amersham Hybond-P PVDF membrane; GE Healthcare, Buckinghamshire, UK) in transfer buffer containing 25 mM Tris-HCl (pH 8.3), 192 mM glycine, and 20% methanol (80 V for 6 h at room temperature). After incubation in blocking buffer (either 5% non-fat milk or 5% BSA in Tris-buffered saline supplemented with 0.1% Tween 20 (TBST)), the blots were incubated overnight at 4 1C with the appropriate primary antibodies. Blots were then washed with TBST and incubated for 1 h at room temperature in 1:3000 horseradish peroxidase-conjugated secondary antibodies (DAKO). After a final wash with TBST, bound antibodies were visualized using a chemiluminescent substance (Amersham ECL Plus Western Blotting Reagents Components/Solution B; GE Healthcare) and exposed to New Amersham Hyperfilm ECL (GE Healthcare). The mean results of three separate assays are shown and each assay was performed in triplicate. The primary antibodies and dilutions used are summarized in Table 1 .
Expression Plasmid and Transient Transfection
The cDNA encoding full-length mouse Cdx2 was amplified by PCR using the following primers: 5 0 -AGCTTTCAGACTC CGGAGCCTCAGC-3 0 and 5 0 -GTTGGACCCAGCTGGG CAAGAAAT-3 0 (NCBI NM_007673). Amplified DNA samples were cloned into a pcDNA TM 5/FRT/V5-His TOPO vector (Invitrogen) and the plasmid clones were sequenced to confirm the constructs. OE33, OE19, and Het-1A cells were separately grown in six-well dishes, and then transfected with the expression vector in each well, using Lipofectamine TM 2000 Transfection Reagent (Invitrogen). Vector DNA without Cdx2 sequences was used as a negative control. After incubation at 37 1C in a humidified incubator containing 5% CO 2 for 6 h, 2 ml of normal growth medium was exchanged. Samples were then prepared and analyzed using real-time PCR and western blot analysis as described previously.
Small Interfering RNA (siRNA) Knockdown of Cdx2 Expression The siRNA, a specific double-stranded 20-25-nucleotide RNA sequence homologous to the target gene, was used to silence Cdx2 expression. The siRNA oligonucleotide for human Cdx2 was purchased from Santa Cruz Biotechnology (sc-43680). Inhibition of RNA or protein expression was assessed after transient transfection of OE33 and OE19 cells with siRNA. In brief, cells were grown in six-well dishes and transiently transfected with 10 nM of pooled siRNAs using 0.4 ml/ml Lipofectamine 2000 Transfection Reagent (Invitrogen) in a total transfection volume of 2 ml of Dulbecco's modified Eagle's medium containing 10% FBS. After incubation at 37 1C in a humidified incubator containing 5% CO 2 for 6 h, 2 ml of normal growth medium was exchanged. Samples were then prepared and analyzed by real-time PCR and western blot analyses as described previously. 
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Statistical Analysis
All data were obtained from at least three independent experiments and are expressed as the mean ± s.e.m., unless otherwise indicated. Multiple comparisons were performed with ANOVA, followed by Dunnett's test. Differences with a P-value of o0.05 were considered to be statistically significant.
RESULTS

Immunohistochemical Examination of Human Esophageal Tissue Specimens
To elucidate the parameters of Notch signaling (Notch1, Hes1, and ATOH1), Cdx2, and MUC2, we used immunohistochemistry to investigate sections of human esophageal IM with goblet cells (IM( þ )) and columnar epithelia not accompanied by goblet cells (IM(À)). The numbers and clinical characteristics of patients included in this study are shown in Table 3 
We also determined Notch1, Hes1, ATOH1, Cdx2, and MUC2 mRNA expression levels in endoscopic biopsy specimens from IM( þ ) and IM(À) esophageal columnar metaplasia. ATOH1, Cdx2, and MUC2 mRNA expression levels in IM( þ ) samples were significantly greater than those in IM(À) samples, whereas the Hes1 mRNA expression level in IM( þ ) samples was significantly lower than in IM(À) samples, with no significant difference between IM( þ ) and IM(À) samples in Notch1 mRNA expression levels (Figure 1b) .
Effects of Notch Signaling Pathway-Specific Inhibitor on Cdx2 and MUC2 Expressions in Human Esophageal Cells
DAPT is known as a specific g-secretase inhibitor of the Notch signaling pathway. [29] [30] [31] To determine whether DAPT augments Cdx2 and MUC2 mRNA expressions, we investigated its effects on Cdx2 and MUC2 mRNA expressions using OE33, OE19, and Het-1A cells, and found that DAPT augmented those expressions in concentration-and timedependent manners. Similarly, effective inhibition was confirmed by Hes1 and ATOH1 mRNA expressions. ATOH1 mRNA expression was upregulated by DAPT, whereas that of Hes1 was decreased, in concentration-and time-dependent manners (Figures 2a-c) . We also investigated the effects of DAPT on Cdx2 and MUC2 protein expressions in OE33 and OE19 cells, and found that it augmented Cdx2 and MUC2 protein expressions in a concentration-dependent manner. Effective inhibition was confirmed by expression of the intracellular-g-secretase cleaved Notch1 fragment using a specific antibody that recognizes only the cleaved fragment, as well as by Hes1 and ATOH1 protein expressions. DAPT decreased cleaved Notch1 protein expression in OE33 and OE19 cells, whereas Hes1 protein was significantly decreased and ATOH1 increased (Figures 2d and e) .
Effects of Cdx2 Overexpression on Hes1, ATOH1, and MUC2 Expressions in Human Esophageal Cells
To investigate whether Cdx2 overexpression influences ATOH1 mRNA expression in esophageal epithelial cells, we transfected a Cdx2 expression vector into OE33, OE19, and Het-1A cells, and determined the levels of ATOH1 and Hes1 mRNA expressions. After 48 h, cells transfected with the Cdx2 expression construct induced ATOH1 mRNA expression, whereas Hes1 mRNA expression was suppressed. In addition, cells transfected with the Cdx2 expression vector showed induced expression of intestinespecific MUC2 mRNA, and there was no difference between Cdx2-transfected and empty vector-transfected cells with regard to Notch1 mRNA expression level. Het-1A cells responded in the same fashion as OE33 and OE19 cells to Cdx2 overexpression (Figures 3a-c) . Next, ATOH1 protein expression following stimulation with a Cdx2 expression vector was evaluated in OE33 and OE19 cells using western blot analysis. Cells transfected with the Cdx2 expression construct induced ATOH1 and suppressed Hes1 protein expression. Similarly, transfection of the Cdx2 expression vector into those cells induced MUC2 protein expression, with no difference between Cdx2-transfected and empty vector-transfected cells with regard to Notch1 protein expression level (Figures 3d and e) .
Effects of Bile Acids on Hes1, ATOH1, Cdx2, and MUC2 Expressions in Human Esophageal Cells
Bile acids are known to play an important role in the induction of Cdx2 expression and we examined their effects on the Notch signaling pathway. To determine their influence, we investigated the effects of bile acids on Hes1, ATOH1, and Cdx2 mRNA expressions using OE33, OE19, and Het-1A cells. Our results showed that bile acids augmented ATOH1 and Cdx2 mRNA expressions in concentration-and time-dependent manners in all cell lines, whereas MUC2 mRNA expression was consistently augmented by bile acids in all cell lines. On the other hand, Hes1 mRNA expression was suppressed by stimulation with bile acids in concentration-and timedependent manners in all cell lines (Figures 4a-c and f-h) . Therefore, blockade of the Notch signaling pathway by bile acids was followed by inhibition of Hes1 and activation of ATOH1 at mRNA expression levels. Ordinarily, ATOH1 synthesis is inhibited by Hes1. Thus, we also investigated the effects of bile acids on cleaved Notch1, Hes1, ATOH1, Cdx2, and MUC2 protein expressions in all cell lines, and found that ATOH1, Cdx2, and MUC2 protein expressions were augmented in a concentration-dependent manner, whereas Hes1 protein expression was decreased in a concentration-dependent manner, with no difference in cleaved Notch1 protein expression levels (Figures 4d  and e) . These findings indicate that stimulation with bile acids decreased the Notch signaling pathway, thereby increasing ATOH1 and resulting in Cdx2 and MUC2 expressions in all cell lines. (Figures 5a, d , and e). Furthermore, ATOH1 and MUC2 mRNA expressions were significantly decreased, whereas Hes1 mRNA expression was augmented in cells transfected with specific Cdx2 siRNA as compared with the control nonspecific siRNA-transfected cells following bile acid treatment (Figures 5b and c) . Cdx2 protein expression was also clearly knocked down by treatment with Cdx2-specific siRNA, completely abrogating any increase in Cdx2 expression upon treatment with bile acids. Notch1 expression was not affected by treatment with the siRNA targeted to Cdx2 (data not shown). In addition, knockdown of Cdx2 significantly downregulated the expressions of both ATOH1 and MUC2, whereas Hes1 expression was upregulated in cells treated and not treated with bile acids (Figures 5d and e) . To confirm whether MUC2 induction by DAPT occurs via Cdx2 activation, we employed treatment with DAPT and Cdx2-specific siRNA in OE33 and OE19 cells. Real-time PCR analysis showed knockdown of Cdx2 mRNA expression in cells treated with Cdx2-specific siRNA (Figure 5a ). In addition, Hes1 mRNA expression was decreased, whereas ATOH1 mRNA expression was upregulated in DAPT-treated cells. Furthermore, MUC2 mRNA expression was significantly decreased in cells transfected with specific Cdx2 siRNA as compared with the control nonspecific siRNA-transfected cells following DAPT treatment (Figures 5f-h) . Western blot analysis revealed that Cdx2 protein expression was also clearly knocked down by treatment with Cdx2-specific (Figures 5i and j) . In contrast, ATOH1 expression was not affected by treatment with the siRNA targeted to Cdx2. Knockdown of Cdx2 significantly downregulated the expression of MUC2 in cells treated with the vehicle alone. However, upon knockdown of Cdx2 expression, a significant downregulation of MUC2 expression was also observed in cells treated with DAPT. Knockdown of Cdx2 completely abrogated the upregulation of MUC2 expression by DAPT, suggesting that induction of the goblet cell phenotype in Notch-inactivated esophageal epithelial cells is dependent upon upregulation of Cdx2 expression.
DISCUSSION
The present study is the first to demonstrate that the transcriptional network related to the intestine-specific homeobox gene Cdx2 as well as the basic helix-loop-helix transcription factor ATOH1 have important roles in the development of Barrett's epithelium. ATOH1 has been reported to be expressed in epithelial cells of the gut and skin, as well as in other organs. 17, [32] [33] [34] [35] However, it has not been fully revealed whether ATOH1 is expressed in the normal esophagus or that with various types of columnar metaplasia. Cdx2 is reported to be expressed in Barrett's epithelium and a number of studies have found that it is a key mediator in the development of Barrett's esophagus. 11, 21, 25, 35 Previously, we showed that bile acids activated the Cdx2 promoter via NF-kB and stimulated the production of Cdx2 protein in esophageal keratinocytes, which is an important step in the development of Barrett's epithelium. 13 In addition to Cdx2, ATOH1 is also reported to be expressed in Barrett's metaplasia. 18, 19 However, the roles of ATOH1 in the development of Barrett's esophagus remain to be reported. A previous study found that overexpression of Cdx2 induced IM in the stomachs of transgenic mouse and suggested that ATOH1 has a role in the development of IM in that mouse model. 20 Also, Morrow et al 18 suggested that ATOH1 is an important molecular mediator of Barrett's metaplasia and that bile acids stimulate the expression of Cdx2 via ATOH1 expression. Therefore, it is considered that ATOH1 and Cdx2 may have similar roles, and interact with each other in the development of Barrett's esophagus.
In the present study, we found that ATOH1 expression was upregulated in human esophageal IM with goblet cells, but not in columnar epithelium without goblet cells, whereas Hes1 expression was suppressed in esophageal columnar epithelium with IM. Therefore, these results are consistent with previous reports from other groups showing that ATOH1 expression is upregulated in IM of the gut and skin, as well as in other organs. 17, [31] [32] [33] [34] Although different types of cells are present in biopsy samples, our results from human tissues suggest that ATOH1 expression is found in Barrett's epithelium.
The resemblance of metaplastic Barrett's epithelium to colonic epithelium prompted us to apply our insights gained in the study of intestinal epithelium to investigate Barrett's epithelium. Notch signaling plays a dominant role in cell-fate decisions in normal colonic epithelium and, when blocked, proliferative epithelial cells instantaneously convert into goblet cells. 15 The same phenomenon occurs in adenomas of the intestine upon inhibition of the Notch signaling pathway. 36 In the present study, we examined whether the inhibition of Notch signaling in esophageal epithelial cells would trigger a similar transdifferentiation to intestinal goblettype columnar epithelial cells. In g-secretase inhibitor DAPTtreated Barrett's adenocarcinoma cell lines, suppressed Hes1 and forced ATOH1 expression by inhibition of Notch signaling induced Cdx2 and MUC2 expressions. The previous report by Leow et al 15 showed that forced ATOH1 expression in colon cancer cells results in increased MUC2 expression. Moreover, ATOH1 rodent homolog Math1 is required for the development of secretory cells, including goblet cells, in embryonic mouse intestines.
14 Consistent with previous reports, overexpression of ATOH1 by DAPT induced MUC2 mRNA and protein expressions in the present esophageal epithelial cells. However, ATOH1 is a weak inducer of MUC2 as compared with Cdx2, as activation of MUC2 by a Cdx2 expression vector caused an B200-fold increase, whereas that induced by overexpression of ATOH1 with DAPT was B2-fold. Furthermore, in Cdx2-specific siRNA-treated cells, the g-secretase inhibitor DAPT did not augment the expression of MUC2 (Figures 5f-j) . Therefore, MUC2 expression observed in ATOH1-activated cells is considered to be indirect via the expression of Cdx2. Cdx2 is a transcriptional activator of a number of intestine-specific genes, including MUC2, sucrose-isomaltase, guanylyl cyclase C, and intestinal alkaline phosphatase (IAP). [37] [38] [39] [40] [41] Furthermore, ATOH1 also contributes to induction of the inter-regulation network with Cdx2 and indirectly stimulates cellular transdifferentiation into IM.
As a next step, we investigated the inter-regulation mechanism between Cdx2 and ATOH1 in detail. In the present Notch signaling pathway and Barrett's esophagus Y Tamagawa et al study, we found that forced expression of Cdx2 in the studied cells induced ATOH1 and MUC2 expressions, whereas it suppressed Hes1 expression ( Figure 3) . Moreover, MUC2 upregulation correlated very well with Cdx2 upregulation. Simultaneous upregulation of both Cdx2 and MUC2 after transfection of a Cdx2 expression vector into Barrett's adenocarcinoma cells is consistent with previous findings from other groups showing that Cdx2 is directly involved in transcriptional regulation of the MUC2 gene in gastric and colon cancer cells. [39] [40] [41] Furthermore, the present results raise the possibility that forced expression of Cdx2 decreases the Notch signaling pathway, thereby increasing ATOH1 expression via Hes1 suppression in esophageal epithelial cells. However, the mechanisms by which ATOH1 induction occurs via Cdx2 activation have not been fully revealed.
We also investigated whether bile acids induce ATOH1 and Cdx2 expressions in Barrett's adenocarcinoma cells in vitro.
In the present experiments, we found that bile acids augmented ATOH1 and Cdx2 expressions in concentration-and time-dependent manners, whereas that of Hes1 was decreased in the same manner, with no difference in active Notch signaling (cleaved Notch1) expression levels. Furthermore, our results indicate that stimulation with bile acids decreased the Notch signaling pathway, thereby increasing ATOH1 expression via Hes1 suppression and Cdx2 expression in esophageal epithelial cells. However, the mechanisms by which ATOH1 induction occurs following stimulation with bile acids and Cdx2 activation are unknown. Thus, we sought to determine whether bile acids induce ATOH1 and MUC2 expressions via Cdx2 activation in the present cell lines. In Cdx2-specific siRNA-treated cells, bile acids did not change the expression of either ATOH1 or MUC2. Our results also indicate that knockdown of Cdx2 expression abrogated the upregulation of MUC2 expression by bile acids and suggest that stimulation with bile acids induced ATOH1 expression via Cdx2 activation in esophageal epithelial cells. Therefore, it is considered that upregulation of MUC2 expression by bile acids occurs mainly via Cdx2 activation, and our findings also suggest an inter-regulation mechanism between Cdx2 and ATOH1 that contributes to goblet cell formation in the development of Barrett's epithelium. Taken together with our previous findings, 13 these results indicate that overexpression of the transcription factors Cdx2 and ATOH1 induced by bile acids may change the phenotype of esophageal stem cells into columnar cells (Figure 6 ). Recent studies have revealed that the Notch signaling pathway is important for esophageal epithelial homeostasis 42 and development of Barrett's adenocarcinoma. 43 Further research is required for elucidation of the role of the Notch signaling pathway in the development of Barrett's epithelium.
There are several limitations in this study. One of them is that the study was done only on Barrett's adenocarcinoma cell lines (OE33 and OE19) and esophageal squamous epithelial cell line (Het-1A cells). Because cancer cell lines can have other genetic alterations or activated signaling pathways, it is unclear that the metaplasia model they propose is relevant to Barrett's esophagus without dysplasia (intestinal Figure 6 Proposed model for Notch signaling pathway and Cdx2 expression in the development of Barrett's esophagus. Bile acids directly stimulate the expression of Cdx2. Overexpression of Cdx2 directly induces MUC2, whereas that of ATOH1 indirectly induces MUC2 via Cdx2 expression. Figure 5 Effects of Cdx2-specific siRNA on Notch signaling (Notch1, Hes1, and ATOH1), Cdx2, and MUC2 expressions in OE33 and OE19 cells. (a) siRNAmediated knockdown of Cdx2 downregulated Cdx2 mRNA expression in OE33 and OE19 cells. Cells were transfected with either Cdx2-specific siRNA or control nonspecific siRNA and cultured for 48 h, and then RNA was extracted and subjected to real-time PCR. Results are expressed as the mean ± s.e.m. of four experiments. Data were normalized to the expression level of GAPDH. A value of 1 for this ratio was assigned arbitrarily to the data obtained from the control nonspecific siRNA. **Po0.01, statistically significant difference (n ¼ 4 for each group). (b-e) At 48 h after transfection with each siRNA, OE33 (b) and OE19 (c) cells were stimulated with DCA (200 mM) or the vehicle alone for 8 h, and then RNA was extracted and subjected to real-time PCR. Data are expressed as the n-fold increase in transcripts in DCA-stimulated samples over that in the vehicle-treated samples. Results are expressed as the mean±s.e.m. of four experiments. *Po0.05 **Po0.01, statistically significant difference vs control siRNA-transfected samples with DCA treatment. NS indicates that the comparison was not significant (n ¼ 4 for each group). In the same condition, proteins were also extracted for western blot analysis (d, e). Blots shown are representative of three separate experiments. (f-j) At 48 h after transfection with each siRNA, OE33 (f) and OE19 (g) cells were stimulated with DAPT (20 mM) or the vehicle alone for 24 h, and then RNA was extracted and subjected to real-time PCR. Data are expressed as the n-fold increase in transcripts in DAPT-stimulated samples over that in the vehicle-treated samples **Po0.01, statistically significant difference vs control siRNA-transfected samples with DAPT (n ¼ 4 for each group). Expression of the indicated ATOH1 mRNA (h) in OE33 and OE19 cells was quantitated by real-time PCR. Results are expressed as the mean ± s.e.m. of four experiments. **Po0.01, statistically significant difference vs control siRNA-transfected samples without DAPT treatment. NS indicates that the comparison was not significant (n ¼ 4 for each group). In the same condition, proteins were also extracted for western blot analysis (i, j).
Notch signaling pathway and Barrett's esophagus Y Tamagawa et al esophageal epithelial metaplasia). Importantly, however, Het-1A cells responded in the same fashion as OE33 and OE19 cells in this study. Our results should be confirmed using Barrett's cell lines (CP-A, BAR-T, and so on) in the near future.
In conclusion, we found that induction of ATOH1 expression via Hes1 suppression in esophageal epithelial cells in response to bile acids has important functions in the induction of metaplastic changes during Barrett's epithelium development. In addition, our results revealed that the transcriptional network related to the Notch signaling pathway and Cdx2 also has important roles in that development.
